Figure 6. PDGF modulated TGFβ-Activin Receptor-like Kinases (ALKs) signaling pathways in MCs.
(A, B) MCs were treated with neutralizing antibody for TGFβ (10 µg/ml) (NA) or control normal IgY (CTL) for 24 h prior to treatment with PDGF at indicated concentrations for 24 h. Equal amounts of cell lysates were subjected to Western blot. One of three independent experiments is shown.
